Evidence map›Paper›PMID 33338421›Full record

ArticleCell2021

TMEM41B Is a Pan-flavivirus Host Factor.

H-Heinrich Hoffmann, William M Schneider, Kathryn Rozen-Gagnon, Linde A Miles, Felix Schuster, Brandon Razooky, Eliana Jacobson, Xianfang Wu, Soon Yi, Charles M Rudin and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 152 papers.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed
23.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 199 citations in OpenAlex.

  1. Dengue virus infection.Nature reviews. Disease primers · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. VMP1 forms a CaScience advances · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. The SMARCA4-TMEM47 axis plays an essential role in chikungunya virus RNA replication.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  18. Article
  19. Article
  20. Review

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

H-Heinrich HoffmannLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
William M SchneiderLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
Kathryn Rozen-GagnonLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
Linde A MilesHuman Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Felix SchusterLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA; Institute of Virology, Medical Faculty "Carl Gustav Carus", Technische Universität Dresden, Dresden, Germany.
Brandon RazookyLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
Eliana JacobsonLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
Xianfang WuLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
Soon YiLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
Charles M RudinDruckenmiller Center for Lung Cancer Research and Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Margaret R MacDonaldLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
Laura K McMullanVirus Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers of Disease Control and Prevention, Atlanta, GA, USA.
John T PoirierLaura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA. Electronic address: john.poirier@nyulangone.org.
Charles M RiceLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA. Electronic address: ricec@rockefeller.edu.
Rockefeller University · USMemorial Sloan Kettering Cancer Center · USCenters for Disease Control and Prevention · USNYU Langone Health · USUniversity Hospital Carl Gustav Carus · DE

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ANIRBAN MAITRA · 1985 to 2026
$83.1M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Unraveling yellow fever 17D vaccine attenuation: The role of type I interferon and innate immunityR01AI124690 · NIAID · ROCKEFELLER UNIVERSITY · PI Charles M Rice · 2016 to 2026
$8.3M
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016087NIAID NIH HHS R01 AI124690NIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

Flaviviruses pose a constant threat to human health. These RNA viruses are transmitted by the bite of infected mosquitoes and ticks and regularly cause outbreaks. To identify host factors required for flavivirus infection, we performed full-genome loss of function CRISPR-Cas9 screens. Based on these results, we focused our efforts on characterizing the roles that TMEM41B and VMP1 play in the virus replication cycle. Our mechanistic studies on TMEM41B revealed that all members of the Flaviviridae family that we tested require TMEM41B. We tested 12 additional virus families and found that SARS-CoV-2 of the Coronaviridae also required TMEM41B for infection. Remarkably, single nucleotide polymorphisms present at nearly 20% in East Asian populations reduce flavivirus infection. Based on our mechanistic studies, we propose that TMEM41B is recruited to flavivirus RNA replication complexes to facilitate membrane curvature, which creates a protected environment for viral genome replication.

Indexed as

AnimalsAsian PeopleAutophagyCell LineCOVID-19CRISPR-Cas SystemsFlavivirusFlavivirus InfectionsGene Knockout TechniquesGenome-Wide Association StudyHost-Pathogen InteractionsHumansImmunity, InnateMembrane ProteinsPolymorphism, Single NucleotideSARS-CoV-2Membrane ProteinsTMEM41B protein, humanVMP1 protein, humanautophagycoronavirusCRISPRflavivirusflavivirus replication complexmembrane remodelingTMEM41BVMP1

Identifiers

PMID33338421
PMCPMC7954666
OpenAlexW3113360200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.